Drugs / MM-151
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02538627 | Aug 2015 → Oct 2016 | colorectal cancer, head and neck squamous cell carcinoma, non-small cell lung carcinoma | Merrimack Pharmaceuticals | Terminated | No outcome recorded |
| Phase 1 | NCT01520389 | Jan 2012 → Dec 2015 | colorectal cancer, head and neck squamous cell carcinoma, non-small cell lung carcinoma, triple-negative breast carcinoma | Merrimack Pharmaceuticals | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02785068 | Jul 2016 → May 2018 | colorectal cancer | Merrimack Pharmaceuticals | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MM-151 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02538627 ↗ |